210
Participants
Start Date
Not specified
Study Completion Date
October 31, 1998
Lamivudine
Beth Israel Med. Ctr. (Mt. Sinai), New York
NY Univ. HIV/AIDS CRS, New York
Cornell University A2201, New York
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Univ. of Rochester ACTG CRS, Rochester
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Johns Hopkins Adult AIDS CRS, Baltimore
Regional Center for Infectious Disease, Wendover Medical Center CRS, Greensboro
Unc Aids Crs, Chapel Hill
Carolinas HealthCare System, Carolinas Med. Ctr., Charlotte
Emory Univ. Hemophilia Program Office, Atlanta
Univ. of Miami AIDS CRS, Miami
Alabama Therapeutics CRS, Birmingham
The Ohio State Univ. AIDS CRS, Columbus
Case CRS, Cleveland
Univ. of Cincinnati CRS, Cincinnati
University of Minnesota, ACTU, Minneapolis
Northwestern University CRS, Chicago
Cook County Hosp. CORE Ctr., Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr., Omaha
USC CRS, Los Angeles
UCLA CARE Center CRS, Los Angeles
Harbor-UCLA Med. Ctr. CRS, Torrance
Ucsf Aids Crs, San Francisco
Stanford CRS, Palo Alto
San Mateo County AIDS Program, Stanford
Santa Clara Valley Med. Ctr., San Jose
University of Washington AIDS CRS, Seattle
Ucsd, Avrc Crs, San Diego
University of Colorado Hospital CRS, Aurora
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Tulane Hemophilia Treatment Ctr., New Orleans
Beth Israel Deaconess - East Campus A0102 CRS, Boston
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
Washington U CRS, St Louis
Mbeya Med. Research Program, Mbeya Referral Hosp. CRS, Mbeya
Massachusetts General Hospital ACTG CRS, Boston
Bmc Actg Crs, Boston
Puerto Rico-AIDS CRS, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH